Tonix Pharmaceuticals Soars, Then Sinks: What's Next After Tonmya's Approval (Upgrade)

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP ) was down about 20% on Monday despite securing that much-anticipated FDA approval on Friday for its fibromyalgia therapy. Tonmya, which had initially sent shares soaringI’m a retired Wall Street PM specializing in TMT; since kickstarting my career, I’ve spent over two decades in the market navigating the technology landscape, focusing on risk mitigation through the dot com bubble, credit default of ‘08, and, more recently, with the AI boom. In one word, wha ...